Whistleblower News From the Inside -- December 19, 2017

By the C|C Whistleblower Lawyer Team

Athletics and doping: how far we’ve come and how far we have to go – “There is general acknowledgement that doping continues, that its extent is greater than has been admitted and that the future of sport may well be at stake if the problem is not solved.  It is, however, equally clear that there is no genuine commitment by many sport authorities, athletes, coaches and even governments to the eradication of doping.”  Sydney Morning Herald

Second Circuit affirms dismissal of Amgen whistleblower suit – The Court found the whistleblower who alleged Amgen “cost the government billions by falsely advertising quality of life benefits for its anemia biologic Epogen failed to actually identify anything that tricked the government into reimbursing claims for the drug.”  Law360

 Owners of Brooklyn diagnostic testing facilities charged with Medicare fraud – The three defendants were charged with health care fraud, false claims, paying health care kickbacks and money laundering in an alleged fraudulent scheme involving over $44 million in claims to Medicare and private insurers.  DOJ